FDA discovers that the recall of Abbott baby formula was not sanitary.

FDA discovers that the recall of Abbott baby formula was not sanitary.

Federal safety inspectors have revealed that baby formula manufacturer Abbott failed to maintain safe conditions at its Michigan plant. This was linked to a number of infant illnesses.

The Food and Drug Administration published its first inspection results from the Abbott plant. This Abbott plant has been linked to multiple infant hospitalizations including two deaths due to rare bacterial infections. After four infants became ill and needed hospitalization, Abbott recalls three batches of popular powdered infant formulas. Some Similac PM 60/40 Powdered Infant Formulas were included in the recall. Since late January, FDA inspectors were on-site inspecting the Sturgis facility in Michigan.

According to an FDA inspection that concluded last week, Abbott did not maintain clean surfaces when producing and handling powdered formula. Inspectors also found evidence of contamination with the bacteria, known by cronobacter. They identified eight cases between fall 2019 to February 2019.

Abbott stated in a statement that it takes the FDA’s actions to correct this situation very seriously and is working closely with them.

Abbott hasn’t confirmed the number of units that have been recalled. However, the company’s brands include Similac, Alimentum, and EleCare, which are some of the most popular baby formulas in the world. According to the company, it continues to make baby formula at its other facilities in the U.S. as well as overseas.

Due to supply-chain issues, the recalls have increased infant formula shortages.

Although rare, infections with the cronobacter bacteria can prove fatal to babies. In March, the FDA reported that five infants were hospitalized for bacterial infections. Two of these patients had died.

FDA discovers that the recall of Abbott baby formula was not sanitary.

Federal safety inspectors have revealed that baby formula manufacturer Abbott failed to maintain safe conditions at its Michigan plant. This was linked to a number of infant illnesses.

The Food and Drug Administration published its first inspection results from the Abbott plant. This Abbott plant has been linked to multiple infant hospitalizations including two deaths due to rare bacterial infections. After four infants became ill and needed hospitalization, Abbott Recalled Infant Formula three batches of popular powdered infant formulas. Some Similac PM 60/40 Powdered Infant Formulas were included in the recall. Since late January, FDA inspectors were on-site inspecting the Sturgis facility in Michigan.

According to an FDA inspection that concluded last week, Abbott did not maintain clean surfaces when producing and handling powdered formula. Inspectors also found evidence of contamination with the bacteria, known by cronobacter. They identified eight cases between fall 2019 to February 2019.

Abbott stated in a statement that it takes the FDA’s actions to correct this situation very seriously and is working closely with them.

Abbott hasn’t confirmed the number of units that have been recalled. However, the company’s brands include Similac, Alimentum, and EleCare, which are some of the most popular baby formulas in the world. According to the company, it continues to make baby formula at its other facilities in the U.S. as well as overseas.

Due to supply-chain issues, the recalls have increased infant formula shortages.

Although rare, infections with the cronobacter bacteria can prove fatal to babies. In March, the FDA reported that five infants were hospitalized for bacterial infections. Two of these patients had died.

Leave a Reply

Your email address will not be published.